# Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism

> **NCT07243561** · PHASE1,PHASE2 · RECRUITING · sponsor: **Dongfang People's Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Autism Spectrum Disorder (ASD
- Prospective Study

## Interventions

- **BIOLOGICAL:** hUC-MSC-Exos Nasal Spray

## Key facts

- **NCT ID:** NCT07243561
- **Lead sponsor:** Dongfang People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07243561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07243561, "Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07243561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*